CADM4 and demyelinating disease: Interestingly, our data showed that the levels of palm-Cadm4 and ZDHHC3 are downregulated in both LPS and EAE models, suggesting that ZDHHC3-Cadm4 signaling may represent a conserved pathological mechanism underlying various demyelination diseases.